Business News

Giiant Pharma Inc Strengthens its Board of Directors with the Appointment of Dr. Marie Lindner

MONTREAL–()–Giiant Pharma Inc., a preclinical-stage biotech company developing gut-restricted drug therapeutics in gastroenterology, announced the appointment of a seasoned executive as an independent board member.

Dr. Marie Lindner worked in various executive roles in pharmaceutical, biotech, venture capital, start-up and medtech companies, spending over 30 years in multiple therapeutic areas, including gastroenterology.

“I am thrilled to join Giiant’s endeavor in advancing their lead program GT-2018, and to support them with their various development programs. I believe my background and expertise will be an effective complement to the company’s already strong R&D strategy and business development,”…

Click here to view the original article.

Related Posts

You might also like ...